Add to ORKGTamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased incidence of endometrial carcinoma in patients taking tamoxifen. In this article, we report a case of malignant mixed mullerian tumor after tamoxifen use
Tamoxifen plays a critical role in the treatment of hormone receptor-positive breast cancer. Despite...
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment ...
AbstractAimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TA...
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased ...
Tamoxifen is used in the treatment of hormone-responsive breast cancer because of its antiestrogenic...
Case: A 67-year-old multiparous woman received 20 mg tamoxifen daily for four years after surgical t...
Background: Uterine malignant mixed müllerian tumor, also known as carcinosarcoma, is a biphasic tu...
Recent studies have indicated that the tamoxifen-related risk of uterine cor-pus cancer may be espec...
Mullerian adenosarcoma following tamoxifen therapy is a rare condition. Our aim was to report the yo...
BACKGROUND AND OBJECTIVE: Uterine carcinosarcoma, also known as malignant mixed Mullerian...
WOS: 000233289200049PubMed ID: 16343223Tamoxifen (TAM) is widely used in the treatment of breast can...
© 2016, University of Kragujevac, Faculty of Science, All rights reserved. The term ‘mixed Müllerian...
Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It...
AimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TAM) that ...
It is well known that a large number of patients treated with Tamoxifen develops endometrial patholo...
Tamoxifen plays a critical role in the treatment of hormone receptor-positive breast cancer. Despite...
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment ...
AbstractAimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TA...
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased ...
Tamoxifen is used in the treatment of hormone-responsive breast cancer because of its antiestrogenic...
Case: A 67-year-old multiparous woman received 20 mg tamoxifen daily for four years after surgical t...
Background: Uterine malignant mixed müllerian tumor, also known as carcinosarcoma, is a biphasic tu...
Recent studies have indicated that the tamoxifen-related risk of uterine cor-pus cancer may be espec...
Mullerian adenosarcoma following tamoxifen therapy is a rare condition. Our aim was to report the yo...
BACKGROUND AND OBJECTIVE: Uterine carcinosarcoma, also known as malignant mixed Mullerian...
WOS: 000233289200049PubMed ID: 16343223Tamoxifen (TAM) is widely used in the treatment of breast can...
© 2016, University of Kragujevac, Faculty of Science, All rights reserved. The term ‘mixed Müllerian...
Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It...
AimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TAM) that ...
It is well known that a large number of patients treated with Tamoxifen develops endometrial patholo...
Tamoxifen plays a critical role in the treatment of hormone receptor-positive breast cancer. Despite...
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment ...
AbstractAimReport the outcome of 8 patients (pts) with breast cancer (BC) treated with Tamoxifen (TA...